Sarcos Technology and Robotics Corporation — FY2023 Form 10-K
Entity and period: The supplied filing is for Sarcos Technology and Robotics Corporation, not Palladyne AI Corp. It reports the fiscal year ended December 31, 2023; it is an annual report, not a standalone fourth-quarter report. The company traded as STRC. Filing signed February 28, 2024.
Business context
In November 2023, Sarcos shifted its strategy to focus on developing and commercializing a third-party, hardware-agnostic AI/ML robotics software platform, suspending hardware product commercialization and retaining only limited hardware R&D. The platform remained under development, and the company reported no commercial customers for it at year-end. Historical revenue came from development contracts and hardware sales.
Financial performance and position
| Metric | FY2023 | FY2022 |
|---|---|---|
| Revenue | $6.1 million | $14.6 million |
| Cost of revenue | $5.0 million | $11.6 million |
| Gross profit / margin | $1.1 million / 18.0% | $3.0 million / 20.3% |
| Operating expenses | $127.1 million | $191.6 million |
| Operating loss | $(121.0) million | $(177.0) million |
| Net loss | $(115.6) million | $(157.1) million |
| Net loss per share, basic and diluted | $(4.51) | $(6.42) |
| Cash used in operating activities | $(76.6) million | $(65.4) million |
Revenue fell 58%, principally because development contracts completed without replacement; product revenue rose to $0.9 million, largely from two Guardian Sea Class system sales. Operating expenses included $37.9 million of asset write-down and restructuring charges. These included an $11.3 million inventory write-down, accelerated amortization and asset write-offs, facility-related depreciation, contract restructuring, severance, and accelerated stock compensation. FY2022 included a $70.2 million non-cash goodwill impairment; FY2023 had none. Interest income was $3.3 million and other income was $1.9 million in FY2023; the warrant-liability gain was $0.2 million versus $13.4 million in FY2022.
At December 31, 2023, cash, cash equivalents and marketable securities totaled $39.1 million, down from $114.5 million a year earlier. Working capital was $36.6 million, total assets $60.4 million, and stockholders’ equity $40.9 million. Total liabilities were $19.5 million, including $12.4 million of operating lease liabilities; the filing reports no material borrowing debt. Undiscounted minimum lease payments were $15.6 million, including $2.0 million due within 12 months. Backlog was $8.1 million ($6.5 million funded); total estimated contract value, including potential options, was $18.1 million.
Changes, outlook and key risks
- Two workforce reductions in 2023 affected approximately 24% of staff in July and 70% in November. The company reported about 70 full- and part-time employees as of February 1, 2024, and was winding down its Pittsburgh operations.
- Management said existing liquidity should fund operations for at least 12 months from the report date, but also said it may raise capital to bolster reserves. Continued operating cash burn and delays in software commercialization could require earlier financing; equity financing could dilute shareholders, while debt could impose covenants.
- The company expects future revenue to depend primarily on developing and licensing its AI/ML platform, potentially alongside selected development contracts. It gave no specific launch date, revenue target, or quantified guidance. Timing, demand, pricing, customer adoption, and license renewals remain uncertain.
- Key risks include an unfinished product and no commercial software customers, no prior software commercialization or licensing track record, technical and safety defects, competition, reliance on key employees and limited-source hardware suppliers, and potential AI, privacy, cybersecurity, regulatory, and intellectual-property issues.
- Nasdaq had notified the company of noncompliance with the $1.00 minimum bid-price rule, with an initial cure deadline of April 22, 2024. The filing also said its $11.7 million public-float market value was below the $15 million threshold and that a deficiency notice might follow. Delisting could impair liquidity and access to capital.
- Management reported disclosure controls and internal control over financial reporting were effective at year-end. The auditor gave an unqualified opinion on the financial statements; it did not attest to internal-control effectiveness, as permitted for an emerging growth company. No material legal proceeding or loss contingency was reported.
Important facts for investors to verify
- Confirm the issuer: this filing is Sarcos Technology and Robotics Corporation, not Palladyne AI Corp.; confirm whether this is the intended filing.
- Track subsequent filings for software development milestones, commercial launch timing, customer contracts, licensing revenue, and backlog conversion.
- Assess actual cash burn and runway against the $39.1 million year-end liquidity balance and management’s 12-month sufficiency statement; monitor any financing or dilution.
- Review subsequent Nasdaq compliance disclosures and whether bid-price and public-float requirements were cured.
- Follow restructuring savings and remaining costs, including lease commitments and any further workforce or facility changes.